Toni Choueiri, Dana-Farber Cancer institute (IMAGE)

Dana-Farber Cancer Institute

Toni Choueiri, Dana-Farber Cancer institute

Caption

Dr. Toni Choueiri led research showing some patients with a form of advanced kidney cancer benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth.

Credit

Dana-Farber Cancer institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.